John Waddington

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Activities & Behaviors

Living Beings

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Babovic Daniela; Jiang Luning; Gantois Ilse; Lawrence Andrew J; Ferreri Vincenzo; Schütz Günter; Waddington John L; Drago John
Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.
Desbonnet Lieve; Waddington John L; Tuathaigh Colm M P O
Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes?
Tomiyama Katsunori; O'Tuathaigh Colm M; O'Sullivan Gerard J; Kinsella Anthony; Lai Donna; Harvey Richard P; Tighe Orna; Croke David T; Koshikawa Noriaki; Waddington John L
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Waddington (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Babovic Daniela; Jiang Luning; Gantois Ilse; Lawrence Andrew J; Ferreri Vincenzo; Schütz Günter; Waddington John L; Drago John
Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.
Behavioural brain research 2010;206(1):78-87.
2009: Desbonnet Lieve; Waddington John L; Tuathaigh Colm M P O
Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes?
Behavioural brain research 2009;204(2):258-73.
2009: Tomiyama Katsunori; O'Tuathaigh Colm M; O'Sullivan Gerard J; Kinsella Anthony; Lai Donna; Harvey Richard P; Tighe Orna; Croke David T; Koshikawa Noriaki; Waddington John L
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice.
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(2):330-3.
2008: Yang Mao Sheng; Morris Derek W; Donohoe Gary; Kenny Elaine; O'Dushalaine Colm T; Schwaiger Siobhan; Nangle Jeanne Marie; Clarke Sarah; Scully Paul; Quinn John; Meagher David; Baldwin Patrizia; Crumlish Niall; O'Callaghan Eadbhard; Waddington John L; Gill Michael; Corvin Aiden
Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism.
Biological psychiatry 2008;64(2):98-103.
2008: Waddington John L; Brown Alan S; Lane Abbie; Schaefer Catherine A; Goetz Raymond R; Bresnahan Michaeline; Susser Ezra S
Congenital anomalies and early functional impairments in a prospective birth cohort: risk of schizophrenia-spectrum disorder in adulthood.
The British journal of psychiatry : the journal of mental science 2008;192(4):264-7.
2008: O'Tuathaigh Colm M P; O'Connor Anne-Marie; O'Sullivan Gerard J; Lai Donna; Harvey Richard; Croke David T; Waddington John L
Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(2):462-6.
2008: Morris Derek W; Murphy Kevin; Kenny Niamh; Purcell Shaun M; McGhee Kevin A; Schwaiger Siobhan; Nangle Jeanne-Marie; Donohoe Gary; Clarke Sarah; Scully Paul; Quinn John; Meagher David; Baldwin Patrizia; Crumlish Niall; O'Callaghan Eadbhard; Waddington John L; Gill Michael; Corvin Aiden P
Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility.
Biological psychiatry 2008;63(1):24-31.
2007: Babovic Daniela; O'Tuathaigh Colm M; O'Sullivan Gerard J; Clifford Jeremiah J; Tighe Orna; Croke David T; Karayiorgou Maria; Gogos Joseph A; Cotter David; Waddington John L
Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice.
Behavioural brain research 2007;183(2):236-9.
2007: Corvin A; McGhee K A; Murphy K; Donohoe G; Nangle J M; Schwaiger S; Kenny N; Clarke S; Meagher D; Quinn J; Scully P; Baldwin P; Browne D; Walsh C; Waddington J L; Morris D W; Gill M
Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(7):949-53.
2007: Waddington John L; Corvin Aiden P; Donohoe Gary; O'Tuathaigh Colm M P; Mitchell Kevin J; Gill Michael
Functional genomics and schizophrenia: endophenotypes and mutant models.
The Psychiatric clinics of North America 2007;30(3):365-99.
2007: O'Tuathaigh C M P; Babovic D; O'Sullivan G J; Clifford J J; Tighe O; Croke D T; Harvey R; Waddington J L
Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.
Neuroscience 2007;147(1):18-27.
2007: Hennessy Robin J; Baldwin Patrizia A; Browne David J; Kinsella Anthony; Waddington John L
Three-dimensional laser surface imaging and geometric morphometrics resolve frontonasal dysmorphology in schizophrenia.
Biological psychiatry 2007;61(10):1187-94.
2007: Makihara Yasuyuki; Okuda Yaeko; Kawada Chieko; Matsumoto Mitsuhiko; Waddington John L; Koshikawa Noriaki; Tomiyama Katsunori
Differential involvement of cyclase- versus non-cyclase-coupled D1-like dopamine receptors in orofacial movement topography in mice: studies with SKF 83822.
Neuroscience letters 2007;415(1):6-10.
2007: O'Tuathaigh Colm M P; Babovic Daniela; O'Meara Gillian; Clifford Jeremiah J; Croke David T; Waddington John L
Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.
Neuroscience and biobehavioral reviews 2007;31(1):60-78.
2006: Tomiyama Katsunori; Makihara Yasuyuki; Yamamoto Hiroshi; O'Sullivan Gerard; Nally Rachel E; Tighe Orna; Kinsella Anthony; Fienberg Allen A; Grandy David K; Sibley David R; Croke David T; Koshikawa Noriaki; Waddington John L
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(6):437-45.
2006: Fujita Satoshi; Lee Jun; Kiguchi Motori; Uchida Takuya; Cools Alexander R; Waddington John L; Koshikawa Noriaki
Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
European journal of pharmacology 2006;538(1-3):94-100.
2006: O'Sullivan Gerard J; Kinsella Anthony; Grandy David K; Tighe Orna; Croke David T; Waddington John L
Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like interactions.
Synapse (New York, N.Y.) 2006;59(2):107-18.
2006: O'Tuathaigh Colm M; O'Sullivan Gerard J; Kinsella Anthony; Harvey Richard P; Tighe Orna; Croke David T; Waddington John L
Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice.
Neuroreport 2006;17(1):79-83.
2006: Norton Nadine; Moskvina Valentina; Morris Derek W; Bray Nicholas J; Zammit Stanley; Williams Nigel M; Williams Hywel J; Preece Anna C; Dwyer Sarah; Wilkinson Jennifer C; Spurlock Gillian; Kirov George; Buckland Paul; Waddington John L; Gill Michael; Corvin Aiden P; Owen Michael J; O'Donovan Michael C
Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2006;141B(1):96-101.
2006: Hennessy Robin J; McLearie Stephen; Kinsella Anthony; Waddington John L
Facial shape and asymmetry by three-dimensional laser surface scanning covary with cognition in a sexually dimorphic manner.
The Journal of neuropsychiatry and clinical neurosciences 2006;18(1):73-80.
2005: Waddington John L; O'Tuathaigh Colm; O'Sullivan Gerard; Tomiyama Katsunori; Koshikawa Noriaki; Croke David T
Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.
Psychopharmacology 2005;181(4):611-38.
2005: Hennessy Robin J; McLearie Stephen; Kinsella Anthony; Waddington John L
Facial surface analysis by 3D laser scanning and geometric morphometrics in relation to sexual dimorphism in cerebral--craniofacial morphogenesis and cognitive function.
Journal of anatomy 2005;207(3):283-95.
2005: McGhee Kevin A; Morris Derek W; Schwaiger Siobhan; Nangle Jeanne-Marie; Donohoe Gary; Clarke Sarah; Meagher David; Quinn John; Scully Paul; Waddington John L; Gill Michael; Corvin Aiden
Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs.
Schizophrenia research 2005;76(2-3):231-8.
2005: Baldwin Patrizia; Browne David; Scully Paul J; Quinn John F; Morgan Maria G; Kinsella Anthony; Owens John M; Russell Vincent; O'Callaghan Eadbhard; Waddington John L
Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 years.
Schizophrenia bulletin 2005;31(3):624-38.
2005: O'Sullivan Gerard J; Kinsella Anthony; Sibley David R; Tighe Orna; Croke David T; Waddington John L
Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
Synapse (New York, N.Y.) 2005;55(4):201-11.
2004: Makihara Yasuyuki; Yamamoto Hiroshi; Inoue Mai; Tomiyama Katsunori; Koshikawa Noriaki; Waddington John L
Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK&F 82958 as an anomalous agent.
Journal of psychopharmacology (Oxford, England) 2004;18(4):484-95.
2004: Nally Rachel E; Kinsella Anthony; Tighe Orna; Croke David T; Fienberg Allen A; Greengard Paul; Waddington John L
Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background.
The Journal of pharmacology and experimental therapeutics 2004;310(3):1281-7.
2004: O'Sullivan Gerard J; Clifford Jeremiah J; Tomiyama Katsunori; Koshikawa Noriaki; Drago John; Sibley David R; Croke David T; Waddington John L
D1-like dopamine receptor-mediated function in congenic mutants with D1 vs. D5 receptor "knockout".
Journal of receptor and signal transduction research 2004;24(3):107-16.
2004: Meagher David J; Quinn John F; Bourke Stephanie; Linehan Sally; Murphy Patrice; Kinsella Anthony; Mullaney James; Waddington John L
Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population.
Psychiatry research 2004;126(3):217-27.
2004: Williams N M; Preece A; Morris D W; Spurlock G; Bray N J; Stephens M; Norton N; Williams H; Clement M; Dwyer S; Curran C; Wilkinson J; Moskvina V; Waddington J L; Gill M; Corvin A P; Zammit S; Kirov G; Owen M J; O'Donovan M C
Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
Archives of general psychiatry 2004;61(4):336-44.
2004: Hennessy Robin J; Lane Abbie; Kinsella Anthony; Larkin Conall; O'Callaghan Eadbhard; Waddington John L
3D morphometrics of craniofacial dysmorphology reveals sex-specific asymmetries in schizophrenia.
Schizophrenia research 2004;67(2-3):261-8.
2004: Scully Paul J; Owens John M; Kinsella Anthony; Waddington John L
Schizophrenia, schizoaffective and bipolar disorder within an epidemiologically complete, homogeneous population in rural Ireland: small area variation in rate.
Schizophrenia research 2004;67(2-3):143-55.
2004: O'Sullivan Gerard J; Roth Bryan L; Kinsella Anthony; Waddington John L
SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
European journal of pharmacology 2004;486(3):273-80.
2004: Corvin A P; Morris D W; McGhee K; Schwaiger S; Scully P; Quinn J; Meagher D; Clair D St; Waddington J L; Gill M
Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus.
Molecular psychiatry 2004;9(2):208-13.
2004: Morris Derek W; Rodgers Alana; McGhee Kevin A; Schwaiger Siobhan; Scully Paul; Quinn John; Meagher David; Waddington John L; Gill Michael; Corvin Aiden P
Confirming RGS4 as a susceptibility gene for schizophrenia.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;125B(1):50-3.
2004: Tomiyama Katsunori; McNamara Fergal N; Clifford Jeremiah J; Kinsella Anthony; Drago John; Fuchs Sara; Grandy David K; Low Malcolm J; Rubinstein Marcelo; Tighe Orna; Croke David T; Koshikawa Noriaki; Waddington John L
Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 receptor "knockout".
Synapse (New York, N.Y.) 2004;51(1):71-81.
2003: Nally Rachel E; McNamara Fergal N; Clifford Jeremiah J; Kinsella A; Tighe Orna; Croke David T; Fienberg Allen A; Greengard Paul; Waddington John L
Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout'.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(12):2055-63.
2003: Adachi Kazunori; Hasegawa Megumi; Fujita Satoshi; Lee Jun; Cools Alexander R; Waddington John L; Koshikawa Noriaki
Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
European journal of pharmacology 2003;473(1):47-54.
2003: Morris Derek W; McGhee Kevin A; Schwaiger Siobhan; Scully Paul; Quinn John; Meagher David; Waddington John L; Gill Michael; Corvin Aiden P
No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study.
Schizophrenia research 2003;60(2-3):167-72.
2003: Morgan Maria G; Scully Paul J; Youssef Hanafy A; Kinsella Anthony; Owens John M; Waddington John L
Prospective analysis of premature mortality in schizophrenia in relation to health service engagement: a 7.5-year study within an epidemiologically complete, homogeneous population in rural Ireland.
Psychiatry research 2003;117(2):127-35.
2003: McNamara Fergal N; Clifford Jeremiah J; Tighe Orna; Kinsella Anthony; Drago John; Croke David T; Waddington John L
Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(1):86-99.
2002: McNamara Fergal N; Clifford Jeremiah J; Tighe Orna; Kinsella Anthony; Drago John; Fuchs Sara; Croke David T; Waddington John L
Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout".
Synapse (New York, N.Y.) 2002;46(1):19-31.
2002: Scully Paul J; Quinn John F; Morgan Maria G; Kinsella Anthony; O'Callaghan Eadbhard; Owens John M; Waddington John L
First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan-Monaghan study at 5 years.
The British journal of psychiatry. Supplement 2002;43():s3-9.
2002: Tomiyama K; McNamara F N; Clifford J J; Kinsella A; Drago J; Tighe O; Croke D T; Koshikawa N; Waddington J L
Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor 'knockout' mice.
Neuropharmacology 2002;42(5):644-52.
2002: Hennessy Robin J; Kinsella Anthony; Waddington John L
3D laser surface scanning and geometric morphometric analysis of craniofacial shape as an index of cerebro-craniofacial morphogenesis: initial application to sexual dimorphism.
Biological psychiatry 2002;51(6):507-14.
2002: Scully P J; Owens J M; Kinsella A; Waddington John L
Dimensions of psychopathology in bipolar disorder versus other affective and non-affective psychoses among an epidemiologically complete population.
Bipolar disorders 2002;4 Suppl 1():43-4.
2002: Baldwin P A; Scully P J; Quinn J F; Morgan M G; Kinsella A; O'Callaghan E; Owens J M; Waddington J L
First episode bipolar disorder: systematic comparison of incidence with other affective and non-affective psychoses among an epidemiologically complete, rural population.
Bipolar disorders 2002;4 Suppl 1():39-40.
2002: Clifford J J; Drago J; Natoli A L; Wong J Y F; Kinsella A; Waddington J L; Vaddadi K S
Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease.
Neuroscience 2002;109(1):81-8.
2001: Clifford J J; Kinsella A; Tighe O; Rubinstein M; Grandy D K; Low M J; Croke D T; Waddington J L
Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor 'knockout'.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(4):527-36.
2001: Waddington J L; Scully P J; Quinn J F; Meagher D J; Morgan M G
The origin and course of schizophrenia: implications for clinical practice.
Journal of psychiatric practice 2001;7(4):247-52.
2001: Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington J L; Koshikawa N
Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
European journal of pharmacology 2001;423(2-3):171-8.
2001: Waddington J L; Clifford J J; McNamara F N; Tomiyama K; Koshikawa N; Croke D T
The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout').
Progress in neuro-psychopharmacology & biological psychiatry 2001;25(4):925-64.
2001: Meagher D; Quinn J; Murphy P; Kinsella A; Mullaney J; Waddington J L
Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics.
Schizophrenia research 2001;50(1-2):95-103.
2001: Quinn J; Meagher D; Murphy P; Kinsella A; Mullaney J; Waddington J L
Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction.
Schizophrenia research 2001;49(1-2):79-87.
2001: Tomiyama K; McNamara F N; Clifford J J; Kinsella A; Koshikawa N; Waddington J L
Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vs. D(2)-like receptor regulation.
European journal of pharmacology 2001;418(1-2):47-54.
2000: Quinn J; Moran M; Lane A; Kinsella A; Waddington J L
Long-term adaptive life functioning in relation to initiation of treatment with antipsychotics over the lifetime trajectory of schizophrenia.
Biological psychiatry 2000;48(2):163-6.
2000: Clifford J J; Waddington J L
Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonists.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(5):538-44.
2000: Clifford J J; Usiello A; Vallone D; Kinsella A; Borrelli E; Waddington J L
Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor.
Neuropharmacology 2000;39(3):382-90.
1999: Waddington J L; Lane A; Scully P; Meagher D; Quinn J; Larkin C; O'Callaghan E
Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process.
Journal of psychiatric research 1999;33(6):477-89.
1999: Waddington J L; Lane A; Larkin C; O'Callaghan E
The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease.
Biological psychiatry 1999;46(1):31-9.
1999: Youssef H A; Scully P J; Kinsella A; Waddington J L
Geographical variation in rate of schizophrenia in rural Ireland by place at birth vs place at onset.
Schizophrenia research 1999;37(3):233-43.
1999: Adachi K; Ikeda H; Hasegawa M; Nakamura S; Waddington J L; Koshikawa N
SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
European journal of pharmacology 1999;367(2-3):143-9.
1999: Clifford J J; Tighe O; Croke D T; Kinsella A; Sibley D R; Drago J; Waddington J L
Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.
Neuroscience 1999;93(4):1483-9.
1998: Clifford J J; Tighe O; Croke D T; Sibley D R; Drago J; Waddington J L
Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax.
Neuropharmacology 1998;37(12):1595-602.
1998: Waddington J L; Youssef H A; Kinsella A
Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study.
The British journal of psychiatry : the journal of mental science 1998;173():325-9.
1998: Waddington J L; Buckley P F; Scully P J; Lane A; O'Callaghan E; Larkin C
Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics?
Journal of psychiatric research 1998;32(3-4):179-89.
1998: Clifford J J; Waddington J L
Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach.
Psychopharmacology 1998;136(3):284-90.
1998: Waddington J L; Lane A; Scully P J; Larkin C; O'Callaghan E
Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?
The Psychiatric clinics of North America 1998;21(1):123-49.
1998: Waddington J L; Deveney A M; Clifford J; Tighe O; Croke D T; Sibley D R; Drago J
Behavioral analysis of multiple D1-like dopamine receptor subtypes: new agents and studies in transgenic mice with D1A receptor knockout.
Advances in pharmacology (San Diego, Calif.) 1998;42():514-7.
1997: Waddington J L; Scully P J; O'Callaghan E
The new antipsychotics, and their potential for early intervention in schizophrenia.
Schizophrenia research 1997;28(2-3):207-22.
1997: Scully P J; Coakley G; Kinsella A; Waddington J L
Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia.
Psychological medicine 1997;27(6):1303-10.
1997: Deveney A M; Waddington J L
Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonists.
Pharmacology, biochemistry, and behavior 1997;58(2):551-8.
1997: Scully P J; Coakley G; Kinsella A; Waddington J L
Executive (frontal) dysfunction and negative symptoms in schizophrenia: apparent gender differences in 'static' v. 'progressive' profiles.
The British journal of psychiatry : the journal of mental science 1997;171():154-8.
1997: Waddington J L
Do D2-like dopamine receptors mediate neuronal excitation or inhibition: some functional-behavioural implications.
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 1997;17(2):111-2.
1997: Waddington J L; Scully P J; Youssef H A
Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101.
Schizophrenia research 1997;23(2):107-18.
1996: Deveney A M; Waddington J L
Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
European journal of pharmacology 1996;317(2-3):175-81.
1996: Waddington J L; Youssef H A
Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia.
Psychological medicine 1996;26(4):681-8.
1996: Deveney A M; Waddington J L
Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
Psychopharmacology 1996;124(1-2):40-9.
1996: Waddington J L; Deveney A M
Dopamine receptor multiplicity: "D1-like'-"D2-like' interactions and " D1-like" receptors not linked to adenylate cyclase.
Biochemical Society transactions 1996;24(1):177-82.
1996: Waddington J L; Youssef H A
Familial-genetic and reproductive epidemiology of schizophrenia in rural Ireland: age at onset, familial morbid risk and parental fertility.
Acta psychiatrica Scandinavica 1996;93(1):62-8.
1995: Waddington J L; Youssef H A; Farrell M A; Toland J
Initial 'schizophrenia-like' psychosis in Pick's disease: case study with neuroimaging and neuropathology, and implications for frontotemporal dysfunction in schizophrenia.
Schizophrenia research 1995;18(1):79-82.
1995: Deveney A M; Waddington J L
Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
British journal of pharmacology 1995;116(3):2120-6.
1995: O'Callaghan E; Buckley P; Madigan C; Redmond O; Stack J P; Kinsella A; Larkin C; Ennis J T; Waddington J L
The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging.
Biological psychiatry 1995;38(8):516-24.
1995: Waddington J L; Daly S A; Downes R P; Deveney A M; McCauley P G; O'Boyle K M
Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(5):811-31.
1995: Buckley P; O'Callaghan E; Mulvany F; Larkin C; Stack J P; Redmond O; Ennis J T; Thompson P; Waddington J L
Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia.
Psychiatry research 1995;61(2):95-102.
1995: McCauley P G; O'Boyle K M; Waddington J L
Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions.
Neuropharmacology 1995;34(7):777-83.
1995: Waddington J L; O'Callaghan E; Buckley P; Madigan C; Redmond O; Stack J P; Kinsella A; Larkin C; Ennis J T
Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.
The British journal of psychiatry : the journal of mental science 1995;167(1):41-4.
1995: Waddington J L; Youssef H A; Kinsella A
Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia.
Psychological medicine 1995;25(4):849-57.
1995: Lane A; Byrne M; Mulvany F; Kinsella A; Waddington J L; Walsh D; Larkin C; O'Callaghan E
Reproductive behaviour in schizophrenia relative to other mental disorders: evidence for increased fertility in men despite decreased marital rate.
Acta psychiatrica Scandinavica 1995;91(4):222-8.
1995: Waddington J L
Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
Advances in neurology 1995;65():211-29.
1994: Buckley P F; Moore C; Long H; Larkin C; Thompson P; Mulvany F; Redmond O; Stack J P; Ennis J T; Waddington J L
1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.
Biological psychiatry 1994;36(12):792-800.
1994: Daly S A; Waddington J L
The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.
British journal of pharmacology 1994;113(3):839-44.
1994: Waddington J L; Youssef H A
Evidence for a gender-specific decline in the rate of schizophrenia in rural Ireland over a 50-year period.
The British journal of psychiatry : the journal of mental science 1994;164(2):171-6.
1993: Waddington J L
Sight and insight: "visualisation" of auditory hallucinations in schizophrenia?
Lancet 1993;342(8873):692-3.
1993: Youssef H A; Kinsella A; Waddington J L
Gender specificity of geographical variation in morbid risk for schizophrenia in rural Ireland.
Acta psychiatrica Scandinavica 1993;88(2):135-9.
1993: Daly S A; Waddington J L
Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists.
Neuropharmacology 1993;32(5):509-10.
1993: Downes R P; Waddington J L
Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.
European journal of pharmacology 1993;234(1):135-6.
1993: Waddington J L
Schizophrenia: developmental neuroscience and pathobiology.
Lancet 1993;341(8844):531-6.
1993: Buckley P; Stack J P; Madigan C; O'Callaghan E; Larkin C; Redmond O; Ennis J T; Waddington J L
Magnetic resonance imaging of schizophrenia-like psychoses associated with cerebral trauma: clinicopathological correlates.
The American journal of psychiatry 1993;150(1):146-8.
1993: Daly S A; Waddington J L
Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
Psychopharmacology 1993;113(1):45-50.
1992: Waddington J L; Weller M P; Crow T J; Hirsch S R
Schizophrenia, genetic retrenchment, and epidemiologic renaissance. The Sixth Biennial Winter Workshop on Schizophrenia, Badgastein, Austria, January 26-February 1, 1992.
Archives of general psychiatry 1992;49(12):990-4.
1992: O'Callaghan E; Buckley P; Redmond O; Stack J; Ennis J T; Larkin C; Waddington J L
Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis.
Journal of the Royal Society of Medicine 1992;85(4):227-31.
1992: Daly S A; Waddington J L
Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
European journal of pharmacology 1992;213(2):251-8.
1992: Daly S A; Waddington J L
New classes of selective D-1 dopamine receptor antagonist provide further evidence for two directions of D-1:D-2 interaction.
Neurochemistry international 1992;20 Suppl():135S-139S.
1992: O'Boyle K M; Waddington J L
Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
Neuropharmacology 1992;31(2):177-83.
1992: Bukley P; O'Callaghan E; Larkin C; Redmond O; Stack J; Waddington J L
MRI, cerebral pathology, and schizophrenia.
Biological psychiatry 1992;31(2):209-10.
1992: Waddington J L; O'Callaghan E; Buckley P; Larkin C; Redmond O; Stack J; Ennis J T
MR imaging and spectroscopy in schizophrenia in relation to the neurodevelopmental hypothesis.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():118A-119A.
1991: Waddington J L; O'Callaghan E; Buckley P; Larkin C; Redmond O; Stack J; Ennis J T
The age dependencies of MRI abnormalities in schizophrenia suggest early ventricular enlargement but later prominence of cortical atrophy.
Schizophrenia research 1991;5(3):188-9.
1991: Murray A M; Waddington J L
Age-related changes in the regulation of behavior by D-1:D-2 dopamine receptor interactions.
Neurobiology of aging 1991;12(5):431-5.
1991: O'Callaghan E; Redmond O; Ennis R; Stack J; Kinsella A; Ennis J T; Larkin C; Waddington J L
Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy.
Biological psychiatry 1991;29(11):1149-52.
1990: Waddington J L; Youssef H A; Kinsella A
Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
Psychological medicine 1990;20(4):835-42.
1990: O'Callaghan E; Larkin C; Kinsella A; Waddington J L
Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia.
The British journal of psychiatry : the journal of mental science 1990;157():578-84.
1990: Murray A M; Waddington J L
The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
European journal of pharmacology 1990;186(1):79-86.
1990: O'Callaghan E; Larkin C; Waddington J L
Obstetric complications in schizophrenia and the validity of maternal recall.
Psychological medicine 1990;20(1):89-94.
1990: Murray A M; Waddington J L
New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
Pharmacology, biochemistry, and behavior 1990;35(1):105-10.
1990: Waddington J L; O'Callaghan E; Larkin C; Redmond O; Stack J; Ennis J T
Magnetic resonance imaging and spectroscopy in schizophrenia.
The British journal of psychiatry. Supplement 1990;(9):56-65.
1990: Waddington J L
Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.
Psychopharmacology 1990;101(4):431-47.
1989: Murray A M; Waddington J L
Behavioural indices of the interaction of clozapine with D1 and D2 dopamine receptors.
British journal of pharmacology 1989;98 Suppl():814P.
1989: Waddington J L; Brown K; O'Neill J; McKeon P; Kinsella A
Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia.
Psychological medicine 1989;19(4):897-902.
1989: O'Boyle K M; Gaitanopoulos D E; Brenner M; Waddington J L
Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.
Neuropharmacology 1989;28(4):401-5.
1989: Murray A M; Waddington J L
The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
European journal of pharmacology 1989;160(3):377-84.
1989: Youssef H A; Waddington J L
Characterization of abnormal respiratory movements in schizophrenic, bipolar and mentally handicapped patients with typical tardive dyskinesia.
International clinical psychopharmacology 1989;4(1):55-9.
1989: Waddington J L; O'Boyle K M
Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist.
Pharmacology & therapeutics 1989;43(1):1-52.
1989: Waddington J L
Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms.
International review of neurobiology 1989;31():297-353.
1989: Murray A M; Waddington J L
Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502.
Psychopharmacology 1989;98(2):245-50.
1988: Youssef H A; Waddington J L
Calcium metabolism and abnormal involuntary movements (tardive dyskinesia) in psychosis.
Acta psychiatrica Scandinavica 1988;78(4):523-5.
1988: Molloy A G; Waddington J L
Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.
British journal of pharmacology 1988;95(2):335-42.
1988: O'Callaghan E; Larkin C; Redmond O; Stack J; Ennis J T; Waddington J L
'Early-onset schizophrenia' after teenage head injury. A case report with magnetic resonance imaging.
The British journal of psychiatry : the journal of mental science 1988;153():394-6.
1988: Waddington J L; Youssef H A
The expression of schizophrenia, affective disorder and vulnerability to tardive dyskinesia in an extensive pedigree.
The British journal of psychiatry : the journal of mental science 1988;153():376-81.
1988: Waddington J L; Youssef H A
Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium.
The American journal of psychiatry 1988;145(5):613-6.
1988: Youssef H A; Waddington J L
Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia.
Biological psychiatry 1988;23(8):791-6.
1988: Waddington J L
Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.
General pharmacology 1988;19(1):55-60.
1987: O'Boyle K M; Waddington J L
New substituted 1-phenyl-3-benzazepine analogues of SK&F 38393 and N-methyl-thienopyridine analogues of dihydroxynomifensine with selective affinity for the D-1 dopamine receptor in human post-mortem brain.
Neuropharmacology 1987;26(12):1807-10.
1987: Waddington J L; Youssef H A; Dolphin C; Kinsella A
Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
Archives of general psychiatry 1987;44(10):907-12.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

John Waddington

Research Profile (preview)

Disorders

Chemicals & Drugs

Activities & Behaviors

Living Beings

Geographic Areas

Physiology

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of John Waddington (preview)

All Publications